molecularyou.comCrawled Nov 2, 2026
Autoimmune biomarkers aid in early diagnosis and management of chronic immune disorders.
Biomarker testing analyzes blood samples to assess disease risk, monitor trends, and tailor care.
The Molecular You Library now includes 43 new diet and supplement recommendations.
The page compares DNA tests to comprehensive health analytics for health insights.
MolecularYou’s early detection tool uses biomarker analysis to advance autism diagnosis.
MolecularYou provides insights in precision medicine, biomarker testing, and healthcare analytics.
MolecularYou announces breakthrough in early pancreatic cancer detection using blood biomarkers. Learn about our innovative diagnostic approach.
Healthcare veteran Jim Kean joins MolecularYou as CEO to drive precision medicine innovation and company growth
Molecular You presents biomarker testing for longevity and chronic disease prevention at A4M LongevityFest.
Christoph pioneered mass spec methods for protein quantification using Multiple Reaction Monitoring.
David holds a Ph.D. from Yale and is a professor at the University of Alberta.
Gene has over 20 years of experience translating ideas into products and business innovations.
Jim Kean is a senior technology executive focused on consumer-oriented health and wellness digital experiences.
Learn how our science-backed molecular medicine delivers deep biomarker analysis and actionable health insights for predictive, preventative care.
Get in touch with Molecular You. Connect with our team for support, partnerships, or information about our healthcare solutions.
Advanced biomarker testing that delivers personalized insights for early disease risk, lifestyle guidance & proactive health management.
The future of personalized health is multi-omics
The page outlines Molecular You’s assessment terms and conditions for health analytics and diagnostic testing.
The page offers legal information, terms of service, and compliance documentation for Molecular You’s healthcare analytics platform.
The page provides patient consent documentation for Molecular You’s health assessment program.
The page reviews Molecular You’s website terms and conditions for platform use.
NPK partners with Molecular You to advance precision healthcare by leveraging microbial metabolites for preventive medicine. The collaboration focuses on gut health innovations, combining NPK’s expertise with Molecular You’s microbiome-based solutions. Both companies aim to develop targeted health interventions using metabolic insights.
Feb 2026Molecular YouNews article
Molecular You presents its molecular medicine platform at **LongevityFest 2025**, the 33rd Annual A4M World Congress. The company specializes in preventive health solutions, showcasing its technology to industry professionals and researchers in Las Vegas. The event highlights advancements in longevity and personalized healthcare.
Dec 2025Molecular YouNews article
Molecular You presents its molecular medicine platform and participates in a diagnostics panel at the Third Roundtable of Longevity Clinics. The company, based in Novato, California, specializes in preventive health solutions for longevity-focused clinics. The event brings together experts to discuss advancements in diagnostic technologies.
Dec 2025Molecular YouNews article
Molecular You presents its precision health platform at HLTH 2025, a major event for health innovation. The company specializes in molecular medicine and preventive health solutions. Attendees can explore its latest advancements in personalized healthcare technologies.
Oct 2025Molecular YouNews article